BMEZ
BlackRock Health Sciences Trust II
NYSE: BMEZ · FINANCIAL SERVICES · ASSET MANAGEMENT
$14.01
+0.07% today
Updated 2026-04-29
Market cap
$880.64M
P/E ratio
5.55
P/S ratio
8.67x
EPS (TTM)
$2.54
Dividend yield
—
52W range
$13 – $15
Volume
0.2M
BlackRock Health Sciences Trust II (BMEZ) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | $113.72M | $5.24M | $59.66M | $-25.97M | $8.19M | $24.07M |
| Revenue growth (YoY) | — | -95.4% | +1038.2% | -143.5% | +131.5% | +193.8% |
| Cost of revenue | — | — | — | — | $-8.46M | $78.00 |
| Gross profit | — | $5.24M | $6.40M | $-25.97M | $28.87M | $24.07M |
| Gross margin | 0.0% | 100.0% | 10.7% | 100.0% | 352.4% | 100.0% |
| R&D | — | — | — | — | — | — |
| SG&A | $477063.00 | $5.17M | $6.35M | $362164.00 | $299026.00 | $355526.00 |
| Operating income | — | $68856.00 | $53937.00 | $1.54M | $8.46M | $927176.00 |
| Operating margin | 0.0% | 1.3% | 0.1% | -5.9% | 103.3% | 3.9% |
| EBITDA | $113.23M | $1.49B | $59.12M | $-26.47M | $20.02M | $23.50M |
| EBITDA margin | 99.6% | 28331.5% | 99.1% | 101.9% | 244.4% | 97.6% |
| EBIT | — | — | $59.17M | $-26.70M | $22.03M | $24.43M |
| Interest expense | $0.00 | $0.00 | — | — | $55.00 | $78.00 |
| Income tax | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $113.23M | $79.56M | $59.12M | $-26.47M | $20.02M | $23.45M |
| Net income growth (YoY) | — | -29.7% | -25.7% | -144.8% | +175.6% | +17.2% |
| Profit margin | 99.6% | 1517.9% | 99.1% | 101.9% | 244.3% | 97.4% |